Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Outcome of gastrointestinal graft-versus-host disease according to the treatment response.

Tamaki M, Nakasone H, Misaki Y, Yoshimura K, Gomyo A, Hayakawa J, Kusuda M, Akahoshi Y, Ishihara Y, Kawamura K, Tanihara A, Sato M, Terasako-Saito K, Kameda K, Wada H, Kikuchi M, Kimura SI, Kako S, Kanda Y.

Ann Hematol. 2018 Jun 2. doi: 10.1007/s00277-018-3385-7. [Epub ahead of print]

PMID:
29860563
2.

Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells?

Nakasone H, Tabuchi K, Uchida N, Ohno Y, Matsuhashi Y, Takahashi S, Onishi Y, Onizuka M, Kobayashi H, Fukuda T, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Yabe H, Kanda Y.

Br J Haematol. 2018 May 29. doi: 10.1111/bjh.15418. [Epub ahead of print] No abstract available.

PMID:
29808925
3.

Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.

Sakamoto K, Katayama R, Asaka R, Sakata S, Baba S, Nakasone H, Koike S, Tsuyama N, Dobashi A, Sasaki M, Ichinohasama R, Takakuwa E, Yamazaki R, Takizawa J, Maeda T, Narita M, Izutsu K, Kanda Y, Ohshima K, Takeuchi K.

Leukemia. 2018 May 23. doi: 10.1038/s41375-018-0154-5. [Epub ahead of print]

PMID:
29795241
4.

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

Kumar AJ, Kim S, Hemmer MT, Arora M, Spellman SR, Pidala JA, Couriel DR, Alousi AM, Aljurf MD, Cahn JY, Cairo MS, Cutler CS, Farhan S, Gergis U, Hale GA, Hashmi SK, Inamoto Y, Kamble RT, Kharfan-Dabaja MA, MacMillan ML, Marks DI, Nakasone H, Norkin M, Qayed M, Ringden O, Schouten HC, Schultz KR, Solh MM, Teshima T, Urbano-Ispizua A, Verdonck LF, Gale RP, Hamilton BK, Majhail NS, Loren AW.

Blood Adv. 2018 May 8;2(9):1022-1031. doi: 10.1182/bloodadvances.2017013052. Erratum in: Blood Adv. 2018 Jun 12;2(11):1294.

5.

Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis.

Kako S, Fujiwara S, Sato M, Kimura SI, Nakasone H, Ohashi K, Kawakita T, Maeda T, Morishita T, Suzuki R, Fukuda T, Ichinohe T, Kurata M, Atsuta Y, Kanda Y.

Biol Blood Marrow Transplant. 2018 Apr 19. pii: S1083-8791(18)30196-4. doi: 10.1016/j.bbmt.2018.04.015. [Epub ahead of print]

PMID:
29680515
6.

Association between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow Transplantation.

Kusuda M, Kimura SI, Misaki Y, Yoshimura K, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Ugai T, Kameda K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kako S, Tanihara A, Kanda Y.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1367-1371. doi: 10.1016/j.bbmt.2018.02.024. Epub 2018 Mar 27.

PMID:
29518551
7.

Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success.

Kawamura K, Nakasone H, Kurosawa S, Yoshimura K, Misaki Y, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Wada H, Ishihara Y, Sato M, Terasako-Saito K, Kikuchi M, Kimura SI, Tanihara A, Kako S, Kanamori H, Mori T, Takahashi S, Taniguchi S, Atsuta Y, Kanda Y.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1521-1526. doi: 10.1016/j.bbmt.2018.02.004. Epub 2018 Feb 21.

PMID:
29476953
8.

Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.

Akahoshi Y, Kimura SI, Gomyo A, Hayakawa J, Tamaki M, Harada N, Kusuda M, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kako S, Kanda Y.

Infect Dis (Lond). 2018 Apr;50(4):280-288. doi: 10.1080/23744235.2017.1396621. Epub 2017 Oct 31.

PMID:
29087731
9.

Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation.

Wada H, Kanda J, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Tanihara A, Nishida J, Kanda Y.

Hematology. 2018 Jun;23(5):271-276. doi: 10.1080/10245332.2017.1396026. Epub 2017 Oct 31.

PMID:
29086660
10.

Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin.

Kameda K, Kako S, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Kanda J, Tanihara A, Wada H, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kanda Y.

Ann Hematol. 2018 Jan;97(1):169-179. doi: 10.1007/s00277-017-3141-4. Epub 2017 Sep 30.

PMID:
28965134
11.

A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.

Ishihara Y, Tanaka Y, Kobayashi S, Kawamura K, Nakasone H, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Harada N, Kusuda M, Kameda K, Ugai T, Wada H, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Kimura SI, Tanihara A, Kako S, Uchimaru K, Kanda Y.

J Virol. 2017 Sep 12;91(19). pii: e00974-17. doi: 10.1128/JVI.00974-17. Print 2017 Oct 1.

12.

Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation.

Tamaki M, Wada H, Gomyo A, Hayakawa J, Akahoshi Y, Harada N, Kusuda M, Ishihara Y, Kawamura K, Tanihara A, Sato M, Terasako-Saito K, Kameda K, Kikuchi M, Kimura SI, Nakasone H, Kako S, Kanda Y.

Int J Hematol. 2018 Jan;107(1):117-121. doi: 10.1007/s12185-017-2296-z. Epub 2017 Jul 6.

PMID:
28685308
13.

Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors.

Kameda K, Nakasone H, Komiya Y, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Tamaki M, Harada N, Kusuda M, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Tanihara A, Wada H, Terasako-Saito K, Kikuchi M, Kimura SI, Kako S, Kanda Y.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1895-1902. doi: 10.1016/j.bbmt.2017.06.025. Epub 2017 Jul 4.

PMID:
28684373
14.

Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study).

Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kamoshita M, Yokoyama Y, Miyaoka E, Ota S, Kako S, Izutsu K, Kanda Y.

Hematol Oncol. 2018 Feb;36(1):202-209. doi: 10.1002/hon.2452. Epub 2017 Jul 6.

PMID:
28681529
15.

Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.

Kimura SI, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Harada N, Ugai T, Kusuda M, Kameda K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kako S, Tanihara A, Kanda Y.

Infect Dis (Lond). 2017 Oct;49(10):748-757. doi: 10.1080/23744235.2017.1340665. Epub 2017 Jun 20.

PMID:
28631944
16.

Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.

Akahoshi Y, Kimura SI, Gomyo A, Hayakawa J, Tamaki M, Harada N, Kusuda M, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kako S, Kanda Y.

Hematol Oncol. 2018 Feb;36(1):276-284. doi: 10.1002/hon.2427. Epub 2017 May 5.

PMID:
28474740
17.

Modulation of surface stiffness and cell patterning on polymer films using micropatterns.

Sunami H, Shimizu Y, Denda J, Yokota I, Yoshizawa T, Uechi Y, Nakasone H, Igarashi Y, Kishimoto H, Matsushita M.

J Biomed Mater Res B Appl Biomater. 2018 Apr;106(3):976-985. doi: 10.1002/jbm.b.33905. Epub 2017 May 5.

PMID:
28474403
18.

Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion.

Akahoshi Y, Kanda J, Ohno A, Komiya Y, Gomyo A, Hayakawa J, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Shiraki K, Kanda Y.

J Infect Chemother. 2017 Jul;23(7):485-487. doi: 10.1016/j.jiac.2017.02.001. Epub 2017 Mar 2.

PMID:
28262533
19.

Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.

Yamasaki R, Kanda J, Akahoshi Y, Nakano H, Ugai T, Wada H, Kawamura K, Ishihara Y, Sakamoto K, Sato M, Ashizawa M, Machishima T, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Kanda Y.

Int J Hematol. 2017 Jun;105(6):835-840. doi: 10.1007/s12185-017-2188-2. Epub 2017 Feb 6.

PMID:
28168415
20.

Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients.

Kimura SI, Gomyo A, Hayakawa J, Akahoshi Y, Harada N, Ugai T, Komiya Y, Kameda K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kanda J, Kako S, Tanihara A, Kanda Y.

J Infect Chemother. 2017 Mar;23(3):148-153. doi: 10.1016/j.jiac.2016.11.007. Epub 2016 Dec 20.

PMID:
28011352
21.

HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin).

Kako S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kanda Y.

Hematology. 2017 Apr;22(3):129-135. doi: 10.1080/10245332.2016.1231968. Epub 2016 Dec 1.

PMID:
27905258
22.

Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation.

Nakasone H, Fuji S, Yakushijin K, Onizuka M, Shinohara A, Ohashi K, Miyamura K, Uchida N, Takanashi M, Ichinohe T, Atsuta Y, Fukuda T, Ogata M; Complication Working Group of Japanese Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2017 Feb;92(2):171-178. doi: 10.1002/ajh.24613.

23.

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.

Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T; JSHCT GVHD Working Group.

Haematologica. 2016 Dec;101(12):1592-1602. Epub 2016 Aug 4.

24.

Urinary Retention due to Constipation.

Kameda K, Nakasone H.

Intern Med. 2016;55(17):2519. doi: 10.2169/internalmedicine.55.6959. Epub 2016 Sep 1. No abstract available.

25.

Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation.

Akahoshi Y, Kanda J, Gomyo A, Hayakawa J, Komiya Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Kanda Y.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1678-1683. doi: 10.1016/j.bbmt.2016.06.003. Epub 2016 Jun 8.

26.

Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma.

Teramura Y, Kameda K, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Wada H, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda Y.

Rinsho Ketsueki. 2016 May;57(5):597-601. doi: 10.11406/rinketsu.57.597. Japanese.

PMID:
27263784
27.

Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.

Atsuta Y, Hirakawa A, Nakasone H, Kurosawa S, Oshima K, Sakai R, Ohashi K, Takahashi S, Mori T, Ozawa Y, Fukuda T, Kanamori H, Morishima Y, Kato K, Yabe H, Sakamaki H, Taniguchi S, Yamashita T; Late Effect and Quality of Life Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1702-1709. doi: 10.1016/j.bbmt.2016.05.019. Epub 2016 May 28.

28.

Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.

Nakano H, Ashizawa M, Akahoshi Y, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y.

Int J Hematol. 2016 Jul;104(1):110-6. doi: 10.1007/s12185-016-1998-y. Epub 2016 Apr 15.

PMID:
27084256
29.

Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.

Akahoshi Y, Kimura S, Nakano H, Harada N, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y.

Clin Transplant. 2016 Jun;30(6):703-8. doi: 10.1111/ctr.12737. Epub 2016 Apr 21.

PMID:
27019071
30.

High-throughput allogeneic antibody detection using protein microarrays.

Paul J, Sahaf B, Perloff S, Schoenrock K, Wu F, Nakasone H, Coller J, Miklos D.

J Immunol Methods. 2016 May;432:57-64. doi: 10.1016/j.jim.2016.02.009. Epub 2016 Feb 20.

31.

ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.

Sakamoto K, Nakasone H, Togashi Y, Sakata S, Tsuyama N, Baba S, Dobashi A, Asaka R, Tsai CC, Chuang SS, Izutsu K, Kanda Y, Takeuchi K.

Int J Hematol. 2016 Apr;103(4):399-408. doi: 10.1007/s12185-016-1934-1. Epub 2016 Jan 18. Review.

PMID:
26781614
32.

Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes.

Nakasone H, Sahaf B, Tian L, Wang T, Haagenson MD, Schoenrock K, Perloff S, Ryan CE, Wu F, Spellman SR, Lee SJ, Ritz J, Miklos DB; Center for International Blood and Marrow Transplantation.

Haematologica. 2016 Jan;101(1):e30-3. doi: 10.3324/haematol.2015.134551. Epub 2015 Oct 22. No abstract available.

33.

High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation.

Kameda K, Kimura SI, Akahoshi Y, Nakano H, Harada N, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y.

Biol Blood Marrow Transplant. 2016 Feb;22(2):371-377. doi: 10.1016/j.bbmt.2015.09.019. Epub 2015 Sep 28.

34.

Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL.

Kako S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Nishida J, Kanda Y.

Ann Hematol. 2016 Jan;95(1):87-92. doi: 10.1007/s00277-015-2510-0. Epub 2015 Sep 22.

PMID:
26391025
35.

Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.

Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Kaida K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, Murata M; GVHD working group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2016 Jan;51(1):96-102. doi: 10.1038/bmt.2015.205. Epub 2015 Sep 14.

PMID:
26367230
36.

A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation.

Ugai T, Hamamoto K, Kimura S, Akahoshi Y, Nakano H, Harada N, Kameda K, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Okochi T, Kanda J, Kako S, Tanaka O, Kanda Y.

Eur J Radiol. 2015 Dec;84(12):2663-70. doi: 10.1016/j.ejrad.2015.08.020. Epub 2015 Sep 1.

PMID:
26358372
37.

Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma.

Ishihara Y, Kimura S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Usuki K, Kanda Y.

Hematology. 2016 Jan;21(1):19-25. doi: 10.1179/1607845415Y.0000000051. Epub 2015 Sep 9.

PMID:
26352559
38.

Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Nakasone H, Remberger M, Tian L, Brodin P, Sahaf B, Wu F, Mattsson J, Lowsky R, Negrin R, Miklos DB, Meyer E.

Haematologica. 2015 Nov;100(11):1477-85. doi: 10.3324/haematol.2015.125294. Epub 2015 Aug 6.

39.

Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation.

Kawamura K, Hayakawa J, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y.

Int J Hematol. 2015 Aug;102(2):230-7. doi: 10.1007/s12185-015-1810-4. Epub 2015 May 20.

PMID:
25990803
40.

Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.

Nakasone H, Sahaf B, Miklos DB.

Int J Hematol. 2015 May;101(5):438-51. doi: 10.1007/s12185-015-1782-4. Epub 2015 Mar 27. Review.

PMID:
25812839
41.

Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.

Nakasone H, Tian L, Sahaf B, Kawase T, Schoenrock K, Perloff S, Ryan CE, Paul J, Popli R, Wu F, Otani JM, Coller J, Warren EH 3rd, Miklos DB.

Blood. 2015 May 14;125(20):3193-201. doi: 10.1182/blood-2014-11-613323. Epub 2015 Mar 12.

42.

False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation.

Kimura S, Akahoshi Y, Nakano H, Harada N, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y.

J Infect. 2015 May;70(5):520-40. doi: 10.1016/j.jinf.2015.02.012. Epub 2015 Mar 3.

PMID:
25743584
43.

Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation.

Sato M, Kako S, Matsumoto K, Oshima K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Sakamoto K, Kawamura K, Ashizawa M, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Nishida J, Morita K, Kanda Y.

Int J Hematol. 2015 May;101(5):497-504. doi: 10.1007/s12185-015-1756-6. Epub 2015 Feb 12.

PMID:
25672602
44.

Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases.

Kimura SI, Murata T, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y.

Eur J Clin Microbiol Infect Dis. 2015 May;34(5):951-61. doi: 10.1007/s10096-014-2311-8. Epub 2015 Jan 11.

PMID:
25577175
45.

Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation.

Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M; GVHD working group of the Japan Society of Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2015 Apr;50(4):559-65. doi: 10.1038/bmt.2014.293. Epub 2014 Dec 22.

PMID:
25531281
46.

Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning.

Akahoshi Y, Kako S, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Nishida J, Kanda Y.

Hematology. 2015 Aug;20(7):410-5. doi: 10.1179/1607845414Y.0000000217. Epub 2014 Dec 1.

PMID:
25437012
47.

Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation.

Terasako-Saito K, Nakasone H, Tanaka Y, Yamazaki R, Sato M, Sakamoto K, Ishihara Y, Kawamura K, Akahoshi Y, Hayakawa J, Wada H, Harada N, Nakano H, Kameda K, Ugai T, Yamasaki R, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y.

Transpl Infect Dis. 2014 Dec;16(6):930-40. doi: 10.1111/tid.12318. Epub 2014 Nov 28.

PMID:
25430567
48.

Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation.

Yamazaki R, Tanaka Y, Nakasone H, Sato M, Terasako-Saito K, Sakamoto K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y.

Transpl Infect Dis. 2014 Dec;16(6):904-13. doi: 10.1111/tid.12304. Epub 2014 Nov 4.

PMID:
25367140
49.

Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.

Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kako S, Kanda J, Nishida J, Sekiguchi N, Noto S, Kida M, Hangaishi A, Usuki K, Kanda Y.

J Chemother. 2015 Feb;27(2):99-105. doi: 10.1179/1973947814Y.0000000219. Epub 2014 Oct 14.

PMID:
25314911
50.

Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia.

Ishihara Y, Kanda J, Tanaka K, Nakano H, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Watanabe K, Kanda Y.

Int J Hematol. 2014 Dec;100(6):607-10. doi: 10.1007/s12185-014-1650-7. Epub 2014 Aug 13.

PMID:
25115834

Supplemental Content

Loading ...
Support Center